Statin + ezetimibe
Intervention2 papers2 findingsPubChem 54454PubChem 150311ChEBI 9150ChEBI 49040
- Humans1
Outcomes
1Mortality
downin humans1HR 0.85Low certainty
1 study
Mortality
downin humans1HR 0.85Low certainty
Statin + ezetimibe decreases mortality in humans (HR 0.85).
Humansn = 669,036
Ezetimibe Treatment Is Associated with Lower Risk of Incident Cancer: A Nationwide Population-Based Cohort Study · Endocrinology and metabolism (Seoul, Korea) · 2 Sep 2026
Associations
1Cancer
downin humans1HR 0.89Low certainty
1 study
Cancer
downin humans1HR 0.89Low certainty
Statin + ezetimibe lowers the risk of cancer in humans (HR 0.89).
Humansn = 669,036
Ezetimibe Treatment Is Associated with Lower Risk of Incident Cancer: A Nationwide Population-Based Cohort Study · Endocrinology and metabolism (Seoul, Korea) · 2 Sep 2026
Latest
37Endocrinology, Diabetes & MetabolismReview
Efficacy and Safety of Oral Non-Statin Lipid-Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta-Analysis
Journal of Lipid and AtherosclerosisReview
Optimal LDL-C Levels for Ischemic Stroke Prevention: A Neurologist's Perspective
International Journal of Molecular SciencesReview
Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome
American Journal of Cardiovascular DiseaseReview
Residual cardiovascular risk beyond LDL-cholesterol control: what remains unaddressed?
Lipids in Health and DiseaseHumans
Real-world use of bempedoic acid for hypercholesterolaemia: a German multicentre, retrospective, cohort study
Journal of Geriatric CardiologyReview